Skip to main content
Equibles

UBS Group AG

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1610520 ZURICH, V8
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$21,960,568
+$4,514,666 QoQ
Shares Held
657,699
-21.0% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. RARE ranks #72 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in RARE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,960,568 657,699
2026-03-31 $17,445,902 832,740
2025-12-31 $15,382,653 668,811
2025-09-30 $16,454,511 547,025
2025-06-30 $16,014,106 440,432
2025-03-31 $16,999,942 469,482
2024-12-31 $13,700,136 325,651
2024-09-30 $5,169,981 93,069
2024-06-30 $8,051,118 195,891
2024-03-31 $7,898,219 169,163
2023-12-31 $2,764,999 57,821
2023-09-30 $1,653,873 46,392
2023-06-30 $2,927,869 63,470
2023-03-31 $3,006,697 74,980
2022-12-31 $7,648,990 165,098
2022-09-30 $1,227,515 29,643
2022-06-30 $2,812,908 47,149
2022-03-31 $6,705,512 92,337
2021-12-31 $5,329,455 63,378
2021-09-30 $5,067,324 56,185
2021-06-30 $2,443,439 25,626
2021-03-31 $5,650,757 49,629
2020-12-31 $3,824,405 27,627
2020-09-30 $2,149,843 26,157
2020-06-30 $2,481,059 31,719
2020-03-31 $5,812,776 130,830